Dr. Michael Ast named chief medical officer of Ospitek

Michael Ast, MD, of New York City-based Hospital for Special Surgery was named chief medical officer of Ospitek, the medtech company said Nov. 2.

Advertisement

Dr. Ast has been a strategic advisor for the company and helped guide its strategic direction, according to a news release. As chief medical officer, he will help accelerate Ospitek’s product development.

“By applying my experience in orthopedics and passion for innovation, I am excited to elevate our platform’s capabilities, enhance surgical workflows, improve patient outcomes and set a global benchmark for excellence in surgical coordination,” Dr. Ast said in the release.

Ospitek’s VIEW platform leverages artificial intelligence and the Internet of Things to provide interoperable visualization and communication tools.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.